1.5 credits
|
THE PATHOGENESIS OF RETINAL DISEASE
The goal of this CME-accredited symposium and supplement
is to improve clinical knowledge of current research and emerging science
on the pathogenesis and multifactorial nature of retinal disease. In order
for retinal surgeons to provide optimal patient care based on evidence-based
medicine for the management of retinal diseases, it is critical that they understand
the role of genetics, inflammation, hypoxia, and cytokines in various retinal
disease states, as well as the additional impact of underlying systemic disease.
Important in this medical education project will be improving surgeon
understanding of the clinical implications based on the different pathological
mechanisms of retinal disease.
Expires: Wednesday, August 10, 2011
|
|
1.5 credits
|
Comparing Treatment Outcomes and Strategies in Retinal Vein Occlusion (Webcast)
The goal of this activity is to introduce physicians to the latest clinical trial results from two phase 3 studies of antivascular endothelial growth factor (anti-VEGF) in macular edema secondary to CRVO and BRVO. Jointly sponsored by The National Retina Institute and Retina Today. This continuing medical education activity is supported by an unrestricted educational grant from Genentech, Inc.
Release Date: June 2010
Expires: Thursday, June 30, 2011
|
|
|
|
1.5 credits
|
Comparing Treatment Outcomes and Strategies in Retinal Vein Occlusion
The goal of this activity is to introduce physicians to the latest clinical trial results from two phase 3 studies of antivascular endothelial growth factor (anti-VEGF) in macular edema secondary to CRVO and BRVO. Jointly sponsored by The National Retina Institute and Retina Today. This continuing medical education activity is supported by an unrestricted educational grant from Genentech, Inc.
Expires: Saturday, April 30, 2011
|
|
1.5 credits
|
Applying New Data to
Refine the Management of
Retinal Venous Occlusion
The goal of this activity is to introduce physicians to the latest clinical trial results from two phase 3 studies of antivascular endothelial growth factor (anti-VEGF) in macular edema secondary to CRVO and BRVO. Jointly sponsored by The National Retina Institute and Retina Today. This continuing medical education activity is supported by an unrestricted grant from Genentech, Inc.
Expires: Monday, February 28, 2011
|
|
|
1.5 credits
|
Intravitreal Corticosteroids: A Review of Therapeutic and Surgical Applications
By: Articles and discussion featuring course director Timothy G. Murray, MD; and faculty members Julia A. Haller, MD; Allen C. Ho, MD; and Seenu M. Hariprasad, MD.
Jointly sponsored by the Dulaney Foundation and Retina Today. Release date: December 2009. Expiration date: December 2010.
This continuing medical education activity is supported by an unrestricted educational grant from Alcon Laboratories, Inc.
Expires: Friday, December 31, 2010
|
|
1.5 credits
|
Clinical Considerations in Low-Tension Glaucoma
By: Featuring: Robert N. Weinreb, MD, L. Jay Katz, MD, Theodore Krupin, MD and Jeffrey Liebmann, MD
Jointly sponsored by the Dulaney Foundation and Glaucoma Today.
Release date: November 2009. Expiration date: November 2010.
This continuing medical education activity is supported by an unrestricted educational grant from Allergan, Inc.
Expires: Tuesday, November 30, 2010
|
|
|
1.5 credits
|
New and Emerging Treatment Paradigms for Macular Edema in Retinal Vein Occlusion and Diabetic Retinopathy
By: Scott W.Cousins,MD,Moderator
David S. Boyer,MD
Miguel A. Busquets,MD, FACS
Pravin U.Dugel,MD
Jeffrey S. Heier,MD
Michael A. Singer,MD
Jointly sponsored by the Dulaney Foundation and Retina Today.
Release date: October 2009. Expiration date: October 2010.
This continuing medical education activity is supported by an unrestricted educational grant from Allergan, Inc.
Expires: Sunday, October 31, 2010
|
|
1 credit
|
Hot Topics in Glaucoma Care: Highlights of a symposium held during the 2009 World Glaucoma Congress
By: Norbert Pfeiffer,MD
Ivan Goldberg,MBBS, FRANZCO,FRACS
Robert D. Fechtner,MD
Christophe Baudouin,MD
Malik Y.Kahook,MD
Jointly sponsored by the Dulaney Foundation and Glaucoma Today.
Release date: October 2009. Expiration date: October 2010.
This continuing medical education activity is supported by an unrestricted educational grant from Alcon Laboratories, Inc.
Expires: Sunday, October 31, 2010
|
|
|
2 credits
|
Innovations In Combination Therapy For Wet Age-Related Macular Degeneration
By: Featuring: Pravin U. Dugel, MD, Moderator,
Borja Corcóstegui, MD,
Carl C. Awh, MD,
Peter Wiedemann, MD,
Joe O'Sullivan, MD, FRCPI, FFRRCSI,
Tim Jackson, PhD, FRCOphth
Jointly sponsored by the Dulaney Foundation and Retina Today.
Release date: August 2009. Expiration date: August 2010.
This continuing medical education activity is supported by an unrestricted educational grant from Neovista, Inc.
Expires: Thursday, September 30, 2010
|
|
|
